BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21078804)

  • 1. The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection.
    Castellani M; Colombo A; Giordano R; Pusineri E; Canzi C; Longari V; Piccaluga E; Palatresi S; Dellavedova L; Soligo D; Rebulla P; Gerundini P
    J Nucl Med; 2010 Dec; 51(12):1908-16. PubMed ID: 21078804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gated cardiac 13N-NH3 PET for assessment of left ventricular volumes, mass, and ejection fraction: comparison with electrocardiography-gated 18F-FDG PET.
    Khorsand A; Graf S; Eidherr H; Wadsak W; Kletter K; Sochor H; Schuster E; Porenta G
    J Nucl Med; 2005 Dec; 46(12):2009-13. PubMed ID: 16330564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction.
    Yamagishi H; Akioka K; Hirata K; Sakanoue Y; Takeuchi K; Yoshikawa J; Ochi H
    J Nucl Med; 1999 Sep; 40(9):1492-8. PubMed ID: 10492370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT.
    Döbert N; Britten M; Assmus B; Berner U; Menzel C; Lehmann R; Hamscho N; Schächinger V; Dimmeler S; Zeiher AM; Grünwald F
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1146-51. PubMed ID: 15064873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography/computed tomography: evaluation in a porcine model of myocardial infarction.
    Lautamäki R; Schuleri KH; Sasano T; Javadi MS; Youssef A; Merrill J; Nekolla SG; Abraham MR; Lardo AC; Bengel FM
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):299-305. PubMed ID: 19808610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction.
    Gerber BL; Melin JA; Bol A; Labar D; Cogneau M; Michel C; Vanoverschelde JL
    J Nucl Med; 1998 Oct; 39(10):1655-62. PubMed ID: 9776263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 18F-Labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging.
    Kim DY; Kim HS; Reder S; Zheng JH; Herz M; Higuchi T; Pyo AY; Bom HS; Schwaiger M; Min JJ
    J Nucl Med; 2015 Oct; 56(10):1581-6. PubMed ID: 26069304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction.
    Doyle B; Kemp BJ; Chareonthaitawee P; Reed C; Schmeckpeper J; Sorajja P; Russell S; Araoz P; Riederer SJ; Caplice NM
    J Nucl Med; 2007 Oct; 48(10):1708-14. PubMed ID: 17909258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An approach for comparative quantification of myocardial blood flow (O-15-H2O-PET), perfusion (Tc-99m-tetrofosmin-SPECT) and metabolism (F-18-FDG-PET)].
    Schäfer WM; Nowak B; Kaiser HJ; Block S; Koch KC; vom Dahl J; Büll U
    Nuklearmedizin; 2001 Oct; 40(5):164-71. PubMed ID: 11727629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the versatility of cardiac PET/CT: feasibility of delayed contrast enhancement CT for infarct detection in a porcine model.
    Holz A; Lautamäki R; Sasano T; Merrill J; Nekolla SG; Lardo AC; Bengel FM
    J Nucl Med; 2009 Feb; 50(2):259-65. PubMed ID: 19164240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
    Tio RA; Dabeshlim A; Siebelink HM; de Sutter J; Hillege HL; Zeebregts CJ; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Slart RH
    J Nucl Med; 2009 Feb; 50(2):214-9. PubMed ID: 19164219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction].
    Balogh L; Czuriga I; Hunyadi J; Galuska L; Kristóf E; Edes I
    Orv Hetil; 2007 Feb; 148(6):243-9. PubMed ID: 17344174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
    Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
    Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of right ventricular pacing on regional myocardial glucose metabolism.
    Preumont N; Jansens JL; Berkenboom G; van de Borne P; Stoupel E; Goldman S
    Europace; 2005 Nov; 7(6):584-91. PubMed ID: 16216761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
    Beanlands RS; deKemp R; Scheffel A; Nahmias C; Garnett ES; Coates G; Johansen HL; Fallen E
    J Am Coll Cardiol; 1997 Mar; 29(3):537-43. PubMed ID: 9060890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
    Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
    J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
    Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
    Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.